NCT00437853View on ClinicalTrials.gov

Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

February 28, 2007

Conditions
Breast Cancer
Interventions
DRUG

Anastrozole

Trial Locations (1)

14080

Instituto Nacional de Cancerologia de Mexico, Mexico City

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Instituto Nacional de Cancerologia de Mexico

OTHER